These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 21167657
1. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma. Chan EK, Fung S, Gospodarowicz M, Hodgson D, Wells W, Sun A, Pintile M, Tsang RW. Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e781-6. PubMed ID: 21167657 [Abstract] [Full Text] [Related]
2. Low-dose radiotherapy in indolent lymphoma. Rossier C, Schick U, Miralbell R, Mirimanoff RO, Weber DC, Ozsahin M. Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e1-6. PubMed ID: 21398049 [Abstract] [Full Text] [Related]
3. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Haas RL, Poortmans P, de Jong D, Verheij M, van der Hulst M, de Boer JP, Bartelink H. Eur J Cancer; 2005 Aug 01; 41(12):1724-30. PubMed ID: 16039113 [Abstract] [Full Text] [Related]
4. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, Linch D, Robinson M, Jack A, Hoskin P. Radiother Oncol; 2011 Jul 01; 100(1):86-92. PubMed ID: 21664710 [Abstract] [Full Text] [Related]
6. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Son SH, Choi BO, Kim GW, Yang SW, Hong YS, Choi IB, Kim YS. Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):86-91. PubMed ID: 19632068 [Abstract] [Full Text] [Related]
7. Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Jóhannsson J, Specht L, Mejer J, Jensen BA. Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1466-70. PubMed ID: 12459371 [Abstract] [Full Text] [Related]
8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
9. Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma. Ng M, Wirth A, Ryan G, MacManus M, Davis S. Australas Radiol; 2006 Jun 01; 50(3):222-7. PubMed ID: 16732818 [Abstract] [Full Text] [Related]
10. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ. J Clin Oncol; 2003 Nov 15; 21(22):4157-64. PubMed ID: 14615444 [Abstract] [Full Text] [Related]
11. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Murthy V, Thomas K, Foo K, Cunningham D, Johnson B, Norman A, Horwich A. Clin Lymphoma Myeloma; 2008 Aug 15; 8(4):241-5. PubMed ID: 18765312 [Abstract] [Full Text] [Related]
12. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P. J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737 [Abstract] [Full Text] [Related]
13. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia. DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR. J Nucl Med; 1999 Aug 01; 40(8):1317-26. PubMed ID: 10450684 [Abstract] [Full Text] [Related]
14. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, Hart AA, van Oers MH, van der Hulst M, Baars JW, Bartelink H. J Clin Oncol; 2003 Jul 01; 21(13):2474-80. PubMed ID: 12829665 [Abstract] [Full Text] [Related]
15. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma. Tam CS, Wolf M, Prince HM, Januszewicz EH, Westerman D, Lin KI, Carney D, Seymour JF. Cancer; 2006 Jun 01; 106(11):2412-20. PubMed ID: 16649223 [Abstract] [Full Text] [Related]
16. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Ann Hematol; 2005 Apr 01; 84(4):223-6. PubMed ID: 15042316 [Abstract] [Full Text] [Related]
17. Radiation therapy for orbital lymphoma. Zhou P, Ng AK, Silver B, Li S, Hua L, Mauch PM. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):866-71. PubMed ID: 15925453 [Abstract] [Full Text] [Related]
18. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. Horning SJ, Weller E, Kim K, Earle JD, O'Connell MJ, Habermann TM, Glick JH. J Clin Oncol; 2004 Aug 01; 22(15):3032-8. PubMed ID: 15210738 [Abstract] [Full Text] [Related]
19. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Willis CR, Goodrich A, Park K, Waselenko JK, Lucas M, Reese A, Diehl LF, Grever MR, Byrd JC, Flinn IW. Ann Hematol; 2006 May 01; 85(5):301-7. PubMed ID: 16518606 [Abstract] [Full Text] [Related]
20. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Hayes JP, Kuzel TM, Mittal BB. Int J Radiat Oncol Biol Phys; 2013 Mar 01; 85(3):747-53. PubMed ID: 22818412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]